Galidesivir (BCX4430), an adenosine analog and a direct-acting antiviral agent, disrupts viral RNA-dependent RNA polymerase (RdRp) activity. Galidesivir is active in vitro against many RNA viral pathogens, including the filoviruses and emerging infectious agents such as MERS-CoV, SARS-CoV, and SARS-CoV-2. Galidesivir inhibits some negative-sense RNA viruses with EC50s ranging from ~3 to ~68 μM.

• Application:COVID-19-anti-virus
• CAS:249503-25-1
• Formula:C11H15N5O3
• Purity:99.13%
• Manufacturer:MedChemExpress
• Sinonims:BCX4430; Immucillin-A
• Molecular mass:265.27